Shim Soon-Sup, Romero Roberto, Hong Joon-Seok, Park Chan-Wook, Jun Jong Kwan, Kim Beyong Il, Yoon Bo Hyun
Department of Obstetrics and Gynecology, Laboratory of Fetal Medicine Research, College of Medicine, Seoul National University Seoul 110-744, Korea.
Am J Obstet Gynecol. 2004 Oct;191(4):1339-45. doi: 10.1016/j.ajog.2004.06.085.
This study was conducted to determine the frequency and clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of the membranes.
Amniotic fluid was retrieved from 219 patients with preterm premature rupture of the membranes; the fluid was cultured for aerobic and anaerobic bacteria and mycoplasmas and assayed for neutrophil collagenase, which is also known as matrix metalloproteinase-8. Matrix metalloproteinase-8 was used because previous studies indicated that this was a sensitive and specific index of inflammation and that is correlated with the amniotic fluid white blood cell count. Intra-amniotic inflammation was defined as an elevated amniotic fluid matrix metalloproteinase-8 concentration (>23 ng/mL). Nonparametric and survival techniques were used for statistical analysis.
The overall rate of intra-amniotic inflammation was 42% (93/219 samples); proven intra-amniotic infection was detected only in 23% (50/219 samples). Intra-amniotic inflammation with a negative amniotic fluid culture for micro-organisms was found in 23% (51/219 samples) and was as common as proven intra-amniotic infection. Pregnancy outcome was worse in patients with intra-amniotic inflammation and a negative culture than in those patients with a negative culture and without inflammation. There were no differences in the interval-to-delivery or rate of complications between patients with intra-amniotic inflammation and a negative culture and patients with proven amniotic fluid infection.
We conclude that intra-amniotic inflammation, regardless of culture result, is present in 42% of patients with preterm premature rupture of the membranes and that it is a risk factor for impending preterm delivery and adverse outcome. We propose that intra-amniotic inflammation, rather than infection, be used to classify and treat patients with preterm premature rupture of the membranes.
本研究旨在确定胎膜早破患者羊膜腔内炎症的发生率及其临床意义。
从219例胎膜早破患者中获取羊水;对羊水进行需氧菌、厌氧菌和支原体培养,并检测中性粒细胞胶原酶(也称为基质金属蛋白酶-8)。使用基质金属蛋白酶-8是因为先前的研究表明,它是炎症的敏感且特异指标,并且与羊水白细胞计数相关。羊膜腔内炎症定义为羊水基质金属蛋白酶-8浓度升高(>23 ng/mL)。采用非参数和生存技术进行统计分析。
羊膜腔内炎症的总体发生率为42%(93/219份样本);仅在23%(50/219份样本)中检测到确诊的羊膜腔内感染。23%(51/219份样本)的患者羊膜腔内炎症伴羊水微生物培养阴性,其发生率与确诊的羊膜腔内感染相同。羊膜腔内炎症且培养阴性的患者的妊娠结局比培养阴性且无炎症的患者更差。羊膜腔内炎症且培养阴性的患者与确诊羊水感染的患者在分娩间隔或并发症发生率方面无差异。
我们得出结论,42%的胎膜早破患者存在羊膜腔内炎症,无论培养结果如何,且它是即将早产和不良结局的危险因素。我们建议用羊膜腔内炎症而非感染来对胎膜早破患者进行分类和治疗。